Track SERA and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Sera Prognostics Inc
2749 East Parleys Way, Salt Lake City, UT, United States, 84109
IPO
2021
Employees
71
Industry
Medical Devices
Sector
Healthcare
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q1 202616-16
0
Q4 20254-4
0
2-quarter cumulative
20 sells0 buys
Analyst Ratings
No coverage data
No analyst ratings data available